Page last updated: 2024-08-22

n-methylaspartate and sb 239063

n-methylaspartate has been researched along with sb 239063 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aizenman, E; Barone, FC; Erhardt, JA; Herin, GA; Legos, JJ; McLaughlin, B; Parsons, AA; Skaper, SD; Strijbos, PJ	1

Other Studies

1 other study(ies) available for n-methylaspartate and sb 239063

Article	Year
The selective p38 inhibitor SB-239063 protects primary neurons from mild to moderate excitotoxic injury. European journal of pharmacology, 2002, Jun-28, Volume: 447, Issue:1 Topics: Animals; Cell Death; Cell Hypoxia; Cells, Cultured; Enzyme Inhibitors; Excitatory Amino Acid Agonists; Glucose; Hippocampus; Imidazoles; Magnesium; Mitogen-Activated Protein Kinases; N-Methylaspartate; Neurons; Neuroprotective Agents; p38 Mitogen-Activated Protein Kinases; Patch-Clamp Techniques; Prosencephalon; Pyrimidines; Rats; Receptors, N-Methyl-D-Aspartate	2002

Article

Year

The selective p38 inhibitor SB-239063 protects primary neurons from mild to moderate excitotoxic injury.

European journal of pharmacology, 2002, Jun-28, Volume: 447, Issue:1

Topics: Animals; Cell Death; Cell Hypoxia; Cells, Cultured; Enzyme Inhibitors; Excitatory Amino Acid Agonists; Glucose; Hippocampus; Imidazoles; Magnesium; Mitogen-Activated Protein Kinases; N-Methylaspartate; Neurons; Neuroprotective Agents; p38 Mitogen-Activated Protein Kinases; Patch-Clamp Techniques; Prosencephalon; Pyrimidines; Rats; Receptors, N-Methyl-D-Aspartate

2002